These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2567590)

  • 1. [Myocardial infarction: secondary prevention with betablockers].
    Depelchin P; Hammoude H; Degré S
    Ann Cardiol Angeiol (Paris); 1989 Mar; 38(3):155-61. PubMed ID: 2567590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Secondary prevention after myocardial infarction; role of beta blockaders].
    Cohen-Solal A; Seknadji P; Czitrom D; Boudvillain O
    Arch Mal Coeur Vaiss; 1996 Aug; 89 Spec No 3():43-6. PubMed ID: 8949318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary prevention after myocardial infarction: in favor of beta-blockers.
    Lévy S
    J Cardiovasc Pharmacol; 1990; 16 Suppl 6():S50-4. PubMed ID: 1707116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of beta-blockers in the acute phase of myocardial infarction].
    Marcillac-Desruennes M; Weber S; Degeorges M
    Ann Cardiol Angeiol (Paris); 1984 Dec; 33(8):519-23. PubMed ID: 6152138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Stratification of arrhythmia risk and therapeutic options in survivors of acute myocardial infarction].
    Arós Borau F; Loma-Osorio A; Torres Bosco A
    Rev Esp Cardiol; 1996 Mar; 49(3):157-65. PubMed ID: 8685518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ambulatory management of patients after myocardial infarction].
    Bloch A
    Rev Med Suisse Romande; 2000 Feb; 120(2):159-66. PubMed ID: 10748703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta blocking agents in post myocardial infarction patients.
    Campbell RW; Bourke J
    Eur Heart J; 1986 May; 7 Suppl A():119-21. PubMed ID: 2873038
    [No Abstract]   [Full Text] [Related]  

  • 8. Review of beta blocker myocardial infarction trials.
    Goldstein S
    Clin Cardiol; 1989 Jul; 12(7 Suppl 3):III54-7. PubMed ID: 2575021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention of arrhythmia in myocardial infarct (secondary prevention)].
    Gertsch M
    Schweiz Rundsch Med Prax; 1986 Sep; 75(40):1181-7. PubMed ID: 2877483
    [No Abstract]   [Full Text] [Related]  

  • 10. [Secondary prophylaxis with beta blockers after myocardial infarction].
    Bosković D
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():25-34. PubMed ID: 18193807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): a randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction. Second Chinese Cardiac Study (CCS-2) Collaborative Group.
    Second Chinese Cardiac Study (CCS-2) Collaborative Group
    J Cardiovasc Risk; 2000 Dec; 7(6):435-41. PubMed ID: 11189013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of antiarrhythmics in the post-infarction period].
    Dinanian S
    Arch Mal Coeur Vaiss; 2000 Apr; 93(3 Spec No):65-9. PubMed ID: 10816803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alprenolol in acute myocardial infarction: Double-blind trial.
    Briant RB; Norris RM
    N Z Med J; 1970 Mar; 71(454):135-8. PubMed ID: 4392703
    [No Abstract]   [Full Text] [Related]  

  • 14. A review of ongoing trials of beta blockers in the secondary prevention of coronary heart disease.
    Cutler JA
    Circulation; 1983 Jun; 67(6 Pt 2):I62-5. PubMed ID: 6133645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic measures following acute myocardial infarct: differential use of PTCA, surgery and drugs].
    Noll G; Kaufmann U; Wenzel RR; Lüscher TF
    Schweiz Med Wochenschr; 1996 Feb; 126(5):164-76. PubMed ID: 8685687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-blockers in the secondary prevention of myocardial infarction: a review of clinical trials of 12 months or more duration.
    Decorde P
    Pharmatherapeutica; 1984; 3(8):515-25. PubMed ID: 6142464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Necrotic lesions, ischemia and reperfusion: effects of beta blockers].
    Lechat P
    Arch Mal Coeur Vaiss; 1993 Jul; 86 Spec No 4():85-90. PubMed ID: 7905729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac death prevention in post-myocardial infarction patients: a review.
    Boissel JP; Leizorovicz A; Faucomprez C
    Acta Cardiol Suppl; 1980; (25):147-79. PubMed ID: 6103625
    [No Abstract]   [Full Text] [Related]  

  • 19. Early intravenous beta blockade in acute myocardial infarction.
    Yusuf S
    Postgrad Med; 1988 Feb; Spec No():90-5. PubMed ID: 2894666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry).
    Piccini JP; Hranitzky PM; Kilaru R; Rouleau JL; White HD; Aylward PE; Van de Werf F; Solomon SD; Califf RM; Velazquez EJ
    Am J Cardiol; 2008 Dec; 102(11):1427-32. PubMed ID: 19026290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.